LEVOTHYROXINE SODIUM
Generic: LEVOTHYROXINE SODIUM
Hikma Pharmaceuticals USA Inc.Manufacturer
INTRAVENOUSRoute
LEVOTHYROXINE SODIUMActive Substance
2021-05-17Original Approval
LEVOTHYROXINE SODIUM is FDA application NDA214253, sponsored by HIKMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2023-02-06
Levothyroxine Sodium Tablets, USP 112 mcg, 90 tablets per bottle, Rx Only, Manufactured by Lloyd Inc., Shenandoah, IA, 5Sub-Potent Drug: Out of specification for assay at the 24 month interval.
Class II2026-08-06
Levothyroxine Sodium Tablets, USP, 200 mcg (0.2 mg), packaged in a) 90-count bottles (NDC 16729-457-15) and b) 1000-couSubpotent Drug
Class II2026-07-13
Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 10 Tablets (10 x 1) unit dose blisters per carton, Rx only, PackagSubpotent Drug
Class II2025-04-10
Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 1000 bottles, Rx Only, Manufactured for Accord Healthcare, Inc., RSubpotent
Class II2026-07-13
Levothyroxine Sodium Tablets, USP, 150 mcg (0.0150 mg), 10 Tablets (10 x 1) unit dose blisters per carton, Rx only, PackSubpotent Drug
Class II2026-07-13
Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, PackSubpotent Drug
Class II2026-08-06
Levothyroxine Sodium Tablets, USP, 50 mcg (0.05 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, ISubpotent Drug
Class II2026-08-06
Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare,Subpotent Drug
Class II2025-06-20
Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), 1000-count bottle, Rx Only, Manufactured for: Accord Healthcare, ISubpotent Drug: Assay below the approved specification
Class II2024-11-19
Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets Subpotent and Superpotent Drug
Top Reported Reactions
1
FATIGUE
8,321 reports
2
NAUSEA
7,290 reports
3
DIARRHOEA
6,612 reports
4
HEADACHE
6,428 reports
5
DYSPNOEA
6,344 reports
6
DRUG INEFFECTIVE
5,446 reports
7
PAIN
5,349 reports
8
DIZZINESS
5,097 reports
9
VOMITING
4,552 reports
10
ASTHENIA
4,372 reports